| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000250069.1 |
Ponatinib |
Esophageal cancer |
0.023626606 |
Resistant |
| ENSG00000250069.1 |
Ponatinib |
Brain lower grade glioma |
0.008492997 |
Resistant |
| ENSG00000250069.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.017448572 |
Resistant |
| ENSG00000250069.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.007826783 |
Resistant |
| ENSG00000250069.1 |
Ponatinib |
Sarcoma |
0.017029243 |
Sensitive |
